AIDS Vaccine

Source: news.yahoo.com --- 28 days ago
A new collaboration merges the International AIDS Vaccine Initiative and the Center for HIV/AIDS Vaccine Immunology at Duke University. ...

Source: www.washingtonpost.com --- 24 days ago
LAST FALL, after trials of a promising AIDS Vaccine from Merck & Co. came back with alarming results, they were canceled. Health experts knew the significance of that, but when The Post reported on the enormity of the situation last month, many were astounded. Not only did the Vaccine not protect trial participants from infection with HIV, the virus that causes AIDS, but it also appeared to make them more susceptible to contracting the disease. At least a half-dozen other trials were stopped or put on hold. The Merck disappointment was branded as a "catastrophe" by one scientist and as setting the race for a cure "back to square one" by others. The hyperbole is understandable, but some perspective is in order. ...

Source: www.moreover.com --- 1 day ago
The disappointment that followed the cancellation of a Merck Vaccine trial in September 2007 has been replaced by a renewed determination among the scientific community, Alan Bernstein, executive director of the , said ahead of the 25th anniversary of ...

Source: www.moreover.com --- 43 days ago
A Los Angeles Times editorial (latimes.com, 4/1) published today offers possible solutions to concerns raised recently around the failure last September of a promising HIV Vaccine produced by Merck. ...

Source: www.moreover.com --- 44 days ago
The failure of a promising AIDS Vaccine -- which not only didn't prevent HIV infection but may have increased susceptibility to the virus -- led to two conflicting calls for action, neither of which got it right. ...

Source: www.moreover.com --- 18 days ago
London, Apr 24 : Millions of dollars, and countless number of hours have been spent in the effort to find an AIDS Vaccine. The target however, still remains a distant dream, and has leading scientists now believing that it may never be achieved. ...

Source: www.moreover.com --- 18 days ago
Leading HIV/AIDS researchers in Britain and the U.S. are pessimistic about the prospects of developing an HIV Vaccine following the recent failure of a Merck Vaccine candidate, according to a survey conducted by London's Independent, the Independent ...

Source: www.latimes.com --- 40 days ago
The U.S. should focus its funds on providing treatment to people in need. As the catalyst for the call to halt U.S. government funding of AIDS Vaccine research, I was somewhat dismayed by The Times' recent editorial, " Revamping AIDS Vaccine research,” which took issue with the AIDS Healthcare Foundation's position without fully understanding it. ...

Source: www.theglobeandmail.com --- 5 days ago
After the disappointment of a failed trial that actually saw HIV infection rates rise, scientists are determined to try again ...

Source: www.ajc.com --- 7 days ago
Despite the failure last fall of Merck & Co.'s AIDS Vaccine, a fledgling Atlanta biotechnology company, GeoVax Inc., is charging ahead into advanced tests of a new drug that it says shows "significant promise." "We've had excellent results in our early stage human trials," said Emory University's Harriet Robinson, leader of a team of scientists working on the Vaccine. Its Vaccine is the only one of several being developed that is on the verge of being moved into Phase 2 tests by the HIV Vaccine Trials Network, which is supported by the National Institutes of Health. GeoVax's trials are expected to start this summer. ...

Source: www.independent.co.uk --- 20 days ago
We've had about 40 replies from AIDS scientists about our survey on the prospects of an HIV Vaccine. I'd like to thank all of those who spent time on answering the poll. Here are the edited comments of some of the scientists who took part. ...

Source: www.medicinenet.com --- 28 days ago
Title: Boston Trial to Test New HIV/AIDS Vaccine Category: Health News Created: 4/12/2008 2:00:00 AM Last Editorial Review: 4/14/2008 ...

Source: blogs.independent.co.uk --- 20 days ago
By Steve Connor We’ve had about 40 replies from AIDS scientists about our survey on the prospects of an HIV Vaccine. I’d like to thank all of those who spent time on answering the poll. Here are the edited comments... ...

Source: www.baltimoresun.com --- 39 days ago
...

Source: blogs.independent.co.uk --- 21 days ago
Most scientists involved in AIDS research believe that a Vaccine against HIV is further away than ever and some have admitted that effective immunisation against the virus may never be possible, according to an unprecedented poll conducted by The Independent.... ...

Source: www.businesswire.com --- 20 days ago
LOS ANGELES--(BUSINESS WIRE)--Scientific consensus on the prospect for development of an effective preventive AIDS Vaccine is bleak, according to the results of a poll of AIDS researchers ...

Source: www.medicalnewstoday.com --- 16 days ago
The recent failure of a Merck HIV/AIDS Vaccine candidate was a "disappointment," but "failure is the rule" in Vaccine and drug development, Seth Berkley, president and CEO of the International AIDS Vaccine Initiative, writes in a Wall Street Journal opinion piece. ...

Source: www.upi.com --- 20 days ago
A survey of leading U.S. and British AIDS researchers said many scientists see little hope of an effective Vaccine against HIV in the near future. ...

Source: www.medicalnewstoday.com --- 42 days ago
The recent "failure" of a Merck HIV/AIDS Vaccine has "led to two conflicting calls for action, neither of which got it right," a Los Angeles Times editorial says. ...